Nanoscope has scored a phase 2 win for its gene therapy using light-sensitive molecules to treat ... the results show that MCO-010 led to vision function improvements. Specifically, 12 of the ...

A recent study published in Engineering delves into the advancements in wound management, specifically focusing on ...

"This phase-sensitive optical amplifier does not, in principle, generate any extra noise, which contributes to a more sensitive receiver and that error-free data transmission is achieved even when ...

Based on data from the study, a phase 3 confirmatory trial is underway for the humanized monoclonal antibody. “Nipocalimab is engineered to remove immune effector functions including Fc gamma ...

Patients experienced improvement in visual acuity and other retinal functions. Aldeyra Therapeutics announced positive results from a phase 2 trial of ADX-2191 for the treatment of retinitis ...

Data from Beacon’s interim six-month safety and efficacy results from a phase 2, announced May 6, pointed to improvements across “several key measures” of visual function, the private ...

As part of the virtual event, the company will discuss its recently launched pivotal Phase 3 study designed to assess the safety and efficacy of LB1148 for postoperative return of bowel function.